Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype
11 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype
Recurrent colorectal cancer and questions raised by surgical intervention
New radiotherapy techniques target lung cancer with less toxicity
The role of NCRI in promoting collaborative research initiatives
Update on post-operative complications in older patients
Role of the surgeon in geriatric cancer management
Cancer Core Europe: Karolinska Institute
Cancer Core Europe: Questions and answers
ePOSSOM: New free online education for postgraduate surgeons
ESMO 2014 Editor's roundup
E-hospital: Fully coordinated cancer care and research in Europe
ESMO Highlights: Breast cancer